Nektar Therapeutics (NKTR)
79.58
+2.08
(+2.68%)
USD |
NASDAQ |
Apr 13, 14:19
Nektar Therapeutics Accounts Payable (Quarterly) : 10.77M for Dec. 31, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Boston Scientific Corp. | 1.144B |
| Soleno Therapeutics, Inc. | 12.44M |
| Eli Lilly & Co. | 5.379B |
| Regeneron Pharmaceuticals, Inc. | 939.00M |
| Esperion Therapeutics, Inc. | 65.07M |